Stay updated on Oral AT2101 in Gaucher Disease Clinical Trial
Sign up to get notified when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.

Latest updates to the Oral AT2101 in Gaucher Disease Clinical Trial page
- Check6 days agoChange DetectedA new 'Show glossary' option is added and several QC/revision labels were updated or introduced (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The corresponding older items with different capitalization (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter revision updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.1%

- Check41 days agoChange DetectedA Locations section was added with listings for California, Florida, Georgia, Iowa, Kansas, Massachusetts, and Ohio; California Locations, Florida Locations, Georgia Locations, Iowa Locations, Kansas Locations, Massachusetts Locations, and Ohio Locations references were removed, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check70 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedThe site-wide notice about government funding lapses and operating status has been removed, while core study details and eligibility information remain unchanged.SummaryDifference0.4%

- Check91 days agoChange DetectedThe new screenshot shows minor visual/layout updates to the Study Details page, including spacing and labeling tweaks. There are no substantive changes to the study data, sections, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Oral AT2101 in Gaucher Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral AT2101 in Gaucher Disease Clinical Trial page.